Related Experiment Video
Updated: Apr 19, 2026
09:06
Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
10.2K
[Narcolepsy with cataplexy: an autoimmune disease?]
Louis Jacob1, Yves Dauvilliers2
1Master biosciences, École normale supérieure de Lyon, 46, allée d'Italie, 69007 Lyon, France.
Medecine Sciences : M/S
|December 25, 2014
Summary
Narcolepsy type 1 is an immune-linked disorder causing excessive daytime sleepiness and cataplexy due to hypocretin neuron loss. Genetic factors like HLA-DQB1*06:02 and environmental triggers, including certain vaccines, increase narcolepsy risk.
Area of Science:
- Neuroimmunology
- Sleep Medicine
- Genetics
Context:
- Narcolepsy type 1 (NT1), also known as narcolepsy-cataplexy or hypocretin deficiency syndrome, is a rare neurological disorder.
- It is characterized by excessive daytime sleepiness, cataplexy, hypnagogic hallucinations, sleep paralysis, and disrupted nocturnal sleep.
Purpose:
- To elucidate the autoimmune basis and genetic associations of Narcolepsy type 1.
- To identify environmental factors contributing to NT1 pathogenesis, including infections and vaccine exposure.
Summary:
- NT1 is an immune-associated disease resulting from the destruction of hypocretin neurons, crucial for wakefulness.
- A strong genetic predisposition exists, with 98% of NT1 patients positive for HLA-DQB1*06:02, significantly increasing narcolepsy risk.
- Environmental factors like influenza and streptococcal infections, and specifically the Pandemrix H1N1 vaccine, are linked to NT1 development.
Impact:
- Understanding the immune and genetic underpinnings of NT1 is crucial for developing targeted therapies.
- Identifying environmental triggers can inform preventative strategies and risk assessment for Narcolepsy type 1.
Related Concept Videos
01:07Narcolepsy
831
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
831
01:24Sleep-Wake Cycles
3.5K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.5K
01:22Myasthenia Gravis ll: Pathophysiology
1
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
1
01:15REM Sleep Behavior Disorder
2.7K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.7K
01:24Graves Disease II: Pathophysiology
5
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
5
01:20Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K